Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
-
Busy address KBO
11 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHARMA-LOUVE from Seneffe, company number BE0894160549, closed financial year 2025 with a result of € 110,741 after tax. For that financial year PHARMA-LOUVE recorded a gross margin of € 395,901 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 115,268 to € 110,741. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.
€ 1.1 million
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 110,741
▼ 4% vs 2024
Profit after tax over the fiscal year.
€ 648,938
▲ 47% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 700,095.
People and assets in 2025
2.6
Average over the fiscal year, from the social balance sheet.
€ 198,583
▲ 9% vs 2024
€ 76,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 941
▼ 74% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 266,848
▼ 11% vs 2024
€ 31,968 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 182,196
▲ 34% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,231
▲ 12% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 357,463 | € 345,345 | € 410,913 | € 395,901 | ▼ 4% |
| Profit after taxes | € 88,560 | € 67,756 | € 115,268 | € 110,741 | ▼ 4% |
| Equity | € 781,330 | € 849,086 | € 964,354 | € 1,075,095 | ▲ 11% |
| Total debts | € 522,490 | € 524,108 | € 458,100 | € 474,850 | ▲ 4% |
| Cash | € 241,984 | € 307,065 | € 442,379 | € 648,938 | ▲ 47% |
| Land & buildings | € 319,964 | € 305,112 | € 290,259 | € 275,406 | ▼ 5% |
| Retained profit | € 406,330 | € 474,086 | € 589,354 | € 700,095 | ▲ 19% |
| Bank debt | € 371,176 | € 328,957 | € 298,209 | € 266,848 | ▼ 11% |
| Balance sheet total | € 1,303,820 | € 1,373,194 | € 1,422,454 | € 1,549,945 | ▲ 9% |
| Employees (FTE) | 2.6 | 2.7 | 2.6 | 2.6 |
Key figures of PHARMA-LOUVE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA-LOUVE?
What happened at PHARMA-LOUVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 110,741 (▼ 4% vs 2024). filed late Source: NBB ↗
- DEVANTHINIC PHARMA became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in La Louvière. KBO
In short
From € 88,560 profit in 2022 to € 110,741 profit in 2025.
Paid € 128,778 in corporate taxes since 2022.
Best year ever: 2024, with € 115,268 profit.
On average € 152,300 of value added per employee in 2025.
A new publication or filing at PHARMA-LOUVE? We notify you, reason included.
Follow PHARMA-LOUVEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DEVANTHINIC PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMA-LOUVEBehind PHARMA-LOUVE is DEVANTHINIC PHARMA. The shares are held by DEVANTHINIC PHARMA (100%).
Directors
According to the 2025 annual accounts
Director · represented by Anne André
Also active at: PHARMACIE DE LA DRÊVE, PHARMACIE DE BOIS-D'HAINE, PHARMACIE DE BASCOUP, PHARMACIE SENEFFE CENTRE, Pharmacie LOISEAU, PHARMACIE ANNE ANDRE, MARIEC.C-PHARMA, PHARMACIE DE LA GRAND RUE +2 more
since 2014
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue des Canadiens 24
7180 Seneffe
Avenue Max Buset(PAU) 3
7100 La Louvière
Active since 10 December 2007
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
All companies at this address →PHARMACIE DE LA DRÊVE same network
€ 287,815 gross margin · 2025
PHARMACIE DE BOIS-D'HAINE same network
€ 317,344 gross margin · 2025
PHARMACIE DE BASCOUP same network
€ 517,152 gross margin · 2025
PHARMACIE SENEFFE CENTRE same network
€ 576,922 gross margin · 2025
PHARMACIE ANNE ANDRE same network
€ 357,760 gross margin · 2025
+6 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0894.160.549
- VAT number
- BE 0894.160.549
- Registered office
- Rue des Canadiens 24, 7180 Seneffe
- Names & denominations
- PHARMA-LOUVE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 December 2007
- Peppol
- Active · Active since 29 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten